Regenica

San Diego, United States Founded: 2008 • Age: 18 yrs Acquired By Allergan
Anti-aging skin care products are developed using growth factor technology.

About Regenica

Regenica is a Healthcare company based in San Diego (United States) founded in 2008, and was acquired by Allergan in July 2017. Anti-aging skin care products are developed using growth factor technology. The company was acqui-hired. Its focus areas include Life Sciences, Dermatology, Drugs and Aesthetics. Its competitors include Revance Therapeutics, Castle Creek Pharma and Dermavant; 3 of its 3 listed competitors have raised funding.

Company details

Regenica was founded in 2008 and is based in San Diego, United States. Operations focus on the cosmetics sector, where anti-aging skin care items are manufactured through regenerative science. Key products encompass a rejuvenating dual serum, replenishing creme, renew SPF 25, repair complex, revitalizing eye creme, and recovery gel. These items utilize skin rejuvenation growth factor technology for formulation.

Operational Areas
Key Metrics

Investors in Regenica

Regenica has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Allergan.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
A portfolio of generic medicines is developed and manufactured.
1948allergan.comMadison, United States
Premium access

Investor details for Regenica

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Regenica

2 dated milestones of Regenica across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Regenica is founded.
  2. Exit Acquired by Allergan.

Competitors of Regenica

Regenica has 3 listed competitors in our database, 3 of them funded. They include Revance Therapeutics, Castle Creek Pharma and Dermavant.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
revance.com2002Newark, United States$154.56M597
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
castlecreekpharma.com2015Basking Ridge, United States$663.15M72
Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders
dermavant.com2016Phoenix, United States$160M
Small molecule therapeutics for inflammatory skin diseases are developed.
Premium access

Detailed competitors of Regenica

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Dermatology

3 companies that operate in the same segment as Regenica (Dermatology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Regenica

Regenica was founded in 2008.

Regenica is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Regenica was founded in 2008 and is based in San Diego, United States. Operations focus on the cosmetics sector, where anti-aging skin care items are manufactured through regenerative science. Key products encompass a rejuvenating dual serum, replenishing creme, renew SPF 25, repair complex, revitalizing eye creme, and recovery gel. These items utilize skin rejuvenation growth factor technology for formulation.

Regenica's top competitors include Revance Therapeutics, Dermavant and Castle Creek Pharma.

Regenica has 1 investor. Key investors include Allergan.

Yes. Regenica was acquired by Allergan in July 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available